Growth Hormone Deficiency (GHD)Symptoms, Doctors, Treatments, Advances & More
Growth Hormone Deficiency (GHD) Overview
Learn About Growth Hormone Deficiency (GHD)
View Main Condition: Short Stature (Growth Disorders)
M Health Fairview Pediatric Specialty Clinic - Journey
Bradley Miller is a Pediatric Endocrinologist and a Pediatrics provider practicing medicine in Minneapolis, MN. Dr. Miller is rated as an Elite provider by MediFind in the treatment of Growth Hormone Deficiency (GHD). He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Growth Hormone Deficiency (GHD), Pediatric Growth Hormone Deficiency, Hypopituitarism, Short Stature (Growth Disorders), and Hormone Replacement Therapy (HRT). Dr. Miller is board certified in American Board Of Pediatrics American Board Of Pediatrics - Pediatric Endocrinology.
Barrow Neuro-Endocrine Clinic
Kevin Yuen is an Endocrinologist practicing medicine in Phoenix, Arizona. Dr. Yuen is rated as an Elite provider by MediFind in the treatment of Growth Hormone Deficiency (GHD). He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Growth Hormone Deficiency (GHD), Hypopituitarism, Sheehan Syndrome, Hormone Replacement Therapy (HRT), and Endoscopic Transnasal Transsphenoidal Surgery. Dr. Yuen is board certified in Internal Medicine (Sub: Endocrinology, Diabetes & Met and Internal Medicine. Dr. Yuen is currently accepting new patients.
Pediatric Diabetes And Endocrinology-Morristown
Lawrence Silverman is a Pediatrics specialist and a Pediatric Endocrinologist practicing medicine in Morristown, New Jersey. Dr. Silverman is rated as an Elite provider by MediFind in the treatment of Growth Hormone Deficiency (GHD). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Precocious Puberty, Pediatric Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), and Short Stature (Growth Disorders). Dr. Silverman is board certified in American Board Of Pediatrics. Dr. Silverman is currently accepting new patients.
Summary: A prospective, randomized, open-label single-blinded study of 50 subjects with growth hormone deficiency, ages 5 to 15 years in which 25 subjects will initiate rhGH therapy at 0.3mg/kg/week and the remaining 25 subjects will initiate their rhGH treatment at 0.2 mg/kg/week for the first 12 months of treatment. Safety parameters, height velocity, and adult height prediction by bone age determination...
Summary: The OraGrowtH Phase 3 Trial is a multi-national trial. The goals of the trial are to study LUM-201 as a treatment for Pediatric Growth Hormone Deficiency (PGHD) in naive to treatment children and validate the LUM-201 predictive enrichment marker (LUM-201 PEM) strategy to select subjects likely to respond to therapy with daily oral LUM-201.
Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center


